Directory
>
Eric Kelsic
Eric Kelsic
Founder & CEO | Dyno Therapeutics
United States
Eric Kelsic
Summary
Eric Kelsic is the CEO and founder of Dyno Therapeutics, where he leads pioneering efforts in AI-powered gene therapy, specifically focusing on AAV capsid engineering. With a robust academic background including a PhD in Systems Biology from Harvard University, Eric has substantial experience in both research and leadership roles. His work spans various prestigious institutions, including Harvard Medical School and the Wyss Institute, where he applied innovative protein engineering methods. Eric's technical expertise encompasses a wide range of programming languages and biological sciences, making him a versatile leader in the biotech field. He has been recognized with awards such as the National Defense Science and Engineering Graduate Fellowship and was a high school valedictorian. In addition to his scientific endeavors, Eric has a creative side, having designed and marketed wooden puzzle boxes. He is passionate about leveraging technology to advance healthcare solutions and is actively hiring for various roles in his company.
Eric Kelsic
Work Experience
Founder & CEO at
Dyno Therapeutics
May 2018 - Present
Staff Scientist, Lab of George Church at
Wyss Institute at Harvard University
July 2016 - December 2018
Postdoctoral Research Fellow, Lab of George Church at
Harvard Medical School
February 2015 - July 2016
Graduate Student, Lab of Roy Kishony at
Harvard University
August 2008 - January 2015
English Instructor at
Nankai University
August 2007 - June 2008
Researcher and Technician in Chemical Engineering, Smolke Lab at
Caltech
June 2006 - June 2007
Summer Undergraduate Research Fellow at
Caltech With Mason Porter
June 2005 - August 2005
Summer Undergraduate Research Fellow at
National Institute of Standards and Technology (NIST)
June 2004 - August 2004
Summer Undergraduate Research Fellow, Atwater Lab at
Caltech
June 2003 - August 2003
Puzzle Box Inventor at
Self Employed
January 2000 - January 2002
Eric Kelsic
Education
Harvard University, Doctor Of Philosophy (Phd)
January 2008 - January 2015
California Institute of Arts & Technology, Bs
January 2002 - January 2006
Frequently Asked Questions about Eric Kelsic
What is Eric Kelsic email address?
Eric Kelsic's primary email address is ***********@dynotx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Eric Kelsic work for?
Eric Kelsic is a Founder & CEO at Dyno Therapeutics, a company specializing in Commercial physical research.
Where Eric Kelsic graduated from?
Eric Kelsic holds a degree in Systems Biology from Harvard University.
How can I directly contact Eric Kelsic?
To contact Eric Kelsic directly, you can use the email address ***********@dynotx.com. Complete contact information is available upon registration with Muraena.
Who is Eric Kelsic?
Eric Kelsic is the CEO and founder of Dyno Therapeutics, where he leads pioneering efforts in AI-powered gene therapy, specifically focusing on AAV capsid engineering. With a robust academic background including a PhD in Systems Biology from Harvard University, Eric has substantial experience in both research and leadership roles. His work spans various prestigious institutions, including Harvard Medical School and the Wyss Institute, where he applied innovative protein engineering methods. Eric's technical expertise encompasses a wide range of programming languages and biological sciences, making him a versatile leader in the biotech field. He has been recognized with awards such as the National Defense Science and Engineering Graduate Fellowship and was a high school valedictorian. In addition to his scientific endeavors, Eric has a creative side, having designed and marketed wooden puzzle boxes. He is passionate about leveraging technology to advance healthcare solutions and is actively hiring for various roles in his company.
Eric`s contact details
***********@dynotx.com
Colleagues
VP, Head of People
VP, Head of Machine Learning
VP, Head Of Corporate Development
VP, Head of Finance
Professor of Neuroscience
Chief Scientific Officer (CSO)